rs3924231
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006129.5(BMP1):c.1180+116A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.2 in 855,576 control chromosomes in the GnomAD database, including 20,818 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_006129.5 intron
Scores
Clinical Significance
Conservation
Publications
- osteogenesis imperfecta type 13Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- high bone mass osteogenesis imperfectaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- osteogenesis imperfecta type 3Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BMP1 | NM_006129.5 | c.1180+116A>G | intron_variant | Intron 9 of 19 | ENST00000306385.10 | NP_006120.1 | ||
| BMP1 | NM_001199.4 | c.1180+116A>G | intron_variant | Intron 9 of 15 | ENST00000306349.13 | NP_001190.1 | ||
| BMP1 | NR_033403.2 | n.1251+116A>G | intron_variant | Intron 9 of 19 | ||||
| BMP1 | NR_033404.2 | n.1251+116A>G | intron_variant | Intron 9 of 15 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.272 AC: 41350AN: 151856Hom.: 6991 Cov.: 33 show subpopulations
GnomAD4 exome AF: 0.184 AC: 129567AN: 703602Hom.: 13806 Cov.: 9 AF XY: 0.182 AC XY: 66029AN XY: 363790 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.273 AC: 41423AN: 151974Hom.: 7012 Cov.: 33 AF XY: 0.276 AC XY: 20534AN XY: 74290 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:2
- -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at